Everpar Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,092
Closed -$313K 288
2025
Q3
$313K Sell
1,092
-115
-10% -$30.8K 0.12% 195
2025
Q2
$317K Buy
1,207
+138
+13% +$33.6K 0.14% 195
2025
Q1
$249K Sell
1,069
-250
-19% -$60.7K 0.13% 217
2024
Q4
$302K Buy
1,319
+146
+12% +$33.5K 0.15% 185
2024
Q3
$262K Sell
1,173
-307
-21% -$67.5K 0.14% 212
2024
Q2
$301K Buy
1,480
+311
+27% +$63.3K 0.15% 189
2024
Q1
$255K Buy
1,169
+235
+25% +$51.8K 0.16% 195
2023
Q4
$212K Buy
+934
New +$196K 0.1% 264

Other funds holding LH

Everpar Advisors's LH Position: Q4 2025 in Review

Everpar Advisors sold out of Labcorp (LH) in Q4 2025, closing a stake of 1,092 shares — an estimated $313K sold.

Everpar Advisors first reported a position in LH in Q4 2023 and held it in 8 quarters. The position peaked at $317K in Q2 2025. 1,024 funds tracked by Wall St. Rank hold LH as of Q4 2025.

  • Everpar Advisors reported no remaining Labcorp position as of Q4 2025 after selling out during the quarter.
  • Everpar Advisors sold 1,092 Labcorp shares in Q4 2025, an estimated $313K.
  • Everpar Advisors first reported a position in Labcorp in Q4 2023 and held it in 8 quarters.
  • Everpar Advisors's Labcorp position peaked at $317K in Q2 2025.
  • 1,024 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on Everpar Advisors's 13F filing for Q4 2025, filed 7 Jan 2026.